Impaired angiogenesis and lymphangiogenesis in diabetes mellitus

Close metadata

The review summarizes the results of the latest studies dealing with the mechanisms of impaired angio- and lymphangiogenesis in diabetes mellitus and the role of these disorders in the development of the disease and its vascular events.

Keywords:

diabetes mellitus

angiogenesis

lymphangiogenesis

Authors:

Konenkov V.I.

NII klinicheskoĭ i éksperimental'noĭ limfologii Sibirskogo otdeleniia RAMN, Novosibirsk

Klimontov V.V.

Kafedra éndokrinologii Novosibirskogo gosudarstvennogo meditsinskogo universiteta

Kuznetsova I.V.

List of references:

IDF Diabetes Atlas. Fifth edition. International Diabetes Federation; 2011.
Poveshchenko A.F., Konenkov V.I. Mechanisms and factors of angiogenesis. Uspekhi fiziologicheskikh nauk. 2010; 41 (2): 68-89. (In Russ.)
Tongers J., Roncalli J.G., Losordo D.W. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation. Microvasc. Res. 2010; 79 (3): 200-6.
Willard A.L., Herman I.M. Vascular complications and diabetes: current therapies and future challenges. J. Ophthalmol. 2012; 2012: 209538. doi: 10.1155/2012/209538
Butler J.M., Guthrie S.M., Koc M., Afzal A., Caballero S., Brooks H.L. et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest. 2005; 115 (1): 86-93.
Rangasamy S., Srinivasan R., Maestas J., McGuire P.G., Das A. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2011; 52 (6): 3784-91.
Hernández C., Simó R. Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy. Endocrine. 2012; 41 (2): 220-6.
Ogata N., Nishikawa M., Nishimura T., Mitsura Y., Matsumura M. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J. Ophthalmol. 2002; 134 (3): 348-53.
Caballero S., Sengupta N., Afzal A., Chang K.H., Li Calzi S., Guberski D.L. et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes. 2007; 56 (4): 960-7.
Brunner S., Schernthaner G.H., Satler M., Elhenicky M., Hoellerl F., Schmid-Kubista K.E. et al. Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Invest. Ophthalmol. Vis. Sci. 2009; 50 (1): 392-8.
Li Calzi S., Neu M.B., Shaw L.C., Grant M.B. Endothelial progenitor dysfunction in the pathogenesis of diabetic retinopathy: treatment concept to correct diabetes-associated deficits. EPMA J. 2010; 1 (1): 88-100.
Min W., Yamanaka N. Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy. Virchows Arch. Pathol. Anat. Histopathol. 1993; 423 (3): 201-7.
Stout L.C., Whorton E.B. Pathogenesis of extra efferent vessel development in diabetic glomeruli. Hum. Pathol. 2007; 38 (8): 1167-77.
Østerby R., Tapia J., Nyberg G., Tencer J., Willner J., Rippe B. et al. Renal structures in type 2 diabetic patients with elevated albumin excretion rate. APMIS. 2001; 109 (11): 751-61.
Kanesaki Y., Suzuki D., Uehara G., Toyoda M., Katoh T., Sakai H., Watanabe T. Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am. J. Kidney Dis. 2005; 45 (2): 288-94.
Goligorsky M.S., Kuo M.C., Patschan D., Verhaar M.C. Review article: endothelial progenitor cells in renal disease. Nephrology (Carlton). 2009; 14 (3): 291-7.
Dessapt C., Karalliedde J., Hernandez-Fuentes M., Martin P.P., Maltese G., Dattani N. et al. Сirculating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria. Diabetes Care. 2010; 33 (4): 875-7.
Reinhard H., Jacobsen P.K., Lajer M., Tarnow L., Astrup A.S., Kim W.Y. et al. Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy. Nephron Clin. Pract. 2011; 118 (3): 309-14.
Jie K.E., Zaikova M.A., Bergevoet M.W., Westerweel P.E., Rastmanesh M., Blankestijn P.J. et al. Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrol. Dial. Transplant. 2010; 25 (6): 1875-82.
Parfenova E.V., Tkachuk V.A. Influence of hyperglycemia on angiogenic properties of endothelial and progenitor cells of blood vessels. Vestnik RAMN. 2012 (1): 38-44. (In Russ.)
Fadini G.P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F. et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 2005; 45 (9): 1449-57.
van Ark J., Moser J., Lexis C.P., Bekkema F., Pop I., van der Horst I.C. et al. Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. Diabetologia. 2012; 55 (9): 2501-12.
Brunner S., Hoellerl F., Schmid-Kubista K.E., Zeiler F., Schernthaner G., Binder S. et al. Circulating angiopoietic cells and diabetic retinopathy in type 2 diabetes mellitus, with or without macrovascular disease. Invest. Ophthalmol. Vis. Sci. 2011; 52 (7): 4655-62.
Albiero M., Menegazzo L., Boscaro E., Agostini C., Avogaro A., Fadini G.P. Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice. Diabetologia. 2011; 54 (4): 945-53.
Zygalaki E., Kaklamanis L., Nikolaou N.I., Kyrzopoulos S., Houri M., Kyriakides Z. et al. Expression profile of total VEGF, VEGF splice variants and VEGF receptors in the myocardium and arterial vasculature of diabetic and non-diabetic patients with coronary artery disease. Clin. Biochem. 2008; 41 (1-2): 82-7.
Chung A.W., Hsiang Y.N., Matzke L.A., McManus B.M., van Breemen C., Okon E.B. Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature. Circ. Res. 2006; 99 (2): 140-8.
Boodhwani M., Sodha N.R., Mieno S., Xu S.H., Feng J., Ramlawi B. et al. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation. 2007; 116 (11, Suppl.): I31-7.
Bozdag-Turan I., Turan R.G., Turan C.H., Ludovicy S., Akin I., Kische S. et al. Relation between the frequency of CD34+ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes. Cardiovasc. Diabetol. 2011; 10: 107.
Ling L., Shen Y., Wang K., Jiang C., Fang C., Ferro A. et al. Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One. 2012; 7 (11): e50739.
Jung C., Rafnsson A., Shemyakin A., Böhm F., Pernow J. Different subpopulations of endothelial progenitor cells and circulating apoptotic progenitor cells in patients with vascular disease and diabetes. Int. J. Cardiol. 2010; 143 (3): 368-72.
Churdchomjan W., Kheolamai P., Manochantr S. Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control. BMC Endocr. Disord. 2010; 10: 5.
Shen C., Li Q., Zhang Y.C., Ma G. Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways. Biomed. Pharmacother. 2010; 64 (1): 35-43.
Bozdag-Turan I., Turan R.G., Paranskaya L., Arsoy N.S., Turan C.H., Akin I. et al. Correlation between the functional impairment of bone marrow-derived circulating progenitor cells and the extend of coronary artery disease. J. Transl. Med. 2012; 10: 143.
Capla J.M., Grogan R.H., Callaghan M.J. Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast. Reconstr. Surg. 2007; 119 (1): 59-70.
Konenkov V.I., Shevchenko A.V., Prokof'ev V.F., Klimontov V.V., Korolev M.A., Fazullina O.N. et al. Variants associations of vascular endothelial growth factor (VEGF) gene and cytokines (IL-1B, IL-4, IL-6, IL-10, TNFA) genes with type 2 diabetes in women. Sakharnyy diabet. 2012; (3): 4-10. (In Russ.)
Konenkov V.I., Borodin Yu.I., Lyubarskiy M.S. Limfologiya [Limfology]. Novosibirsk: ID "Manuskript" Publ.; 2012.
Ji R.C. Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis. Cell. Mol. Life Sci. 2012; 69 (6): 897-914.
Park C., Lee J.Y., Yoon Y.S. Role of bone marrow-derived lymphatic endothelial progenitor cells for lymphatic neovascularization. Trends Cardiovasc. Med. 2011; 21 (5): 135-40.
Qu P., Ji R.C., Kato S. Histochemical analysis of lymphatic endothelial cells in the pancreas of non-obese diabetic mice. J. Anat. 2003; 203 (5): 523-30.
Yin N., Zhang N., Lal G., Xu J., Yan M., Ding Y., Bromberg J.S. Lymphangiogenesis is required for pancreatic islet inflammation and diabetes. PLoS One. 2011; 6 (11): e28023.
Yin N., Zhang N., Xu J., Shi Q., Ding Y., Bromberg J.S. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Transplantation. 2011; 92 (1): 25-30.
Miller N.E., Michel C.C., Nanjee M.N., Olszewski W.L., Miller I.P., Hazell M. et al. Secretion of adipokines by human adipose tissue in vivo: partitioning between capillary and lymphatic transport. Am. J. Physiol. Endocrinol. Metab. 2011; 301 (4): E659-67.
Arngrim N., Simonsen L., Holst J.J., Bülow J. Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation? Int. J. Obes. (London). 2013; 37 (5): 748-50.
Zampell J.C., Aschen S., Weitman E.S., Yan A., Elhadad S., De Brot M., Mehrara B.J. Regulation of adipogenesis by lymphatic fluid stasis: part I. Adipogenesis, fibrosis, and inflammation. Plast. Reconstr. Surg. 2012; 129 (4): 825-34.
Haemmerle M., Keller T., Egger G., Schachner H., Steiner C.W., Stokic D. et al. Enhanced lymph vessel density, remodelling and inflammation is reflected by gene expression signatures in dermal lymphatic endothelial cells in type 2 diabetes. Diabetes. 2013; 62 (7): 2509-29.
Maruyama K., Asai J., Ii M., Thorne T., Losordo D.W., D'Amore P.A. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am. J. Pathol. 2007; 170 (4): 1178-91.
Wei M., XueY.-M., Sha J.-P., Zeng Z.-J., Zou Y., Zhuo F.-T. Expression of vascular endothelial growth factor 3 in non-ischemic diabetic foot ulcer. J. Clin. Rehab. Tis. Eng. Res. 2008; 12 (42): 8221-4.
Saaristo A., Tammela T., Farkkilā A., Kärkkäinen M., Suominen E., Yla-Herttuala S., Alitalo K. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 2006; 169 (3): 1080-7.

Close metadata